Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

AbbVie coaxes Shire into discussions with sweetened offer

Raises takeover bid to $53bn

Biogen Idec building

NICE green light for Biogen’s oral MS drug

Overturns previous negative guidance for Tecfidera

- PMLiVE

US senators seeks answers on Sovaldi pricing

Gilead asked to justify pricing of hepatitis drug

The seven letter debate that is Sovaldi

Reimbursement of high cost hepatitis C drugs raise difficult issues

- PMLiVE

Eisai’s Bose to join Boehringer

He becomes head of global marketing for oncology

- PMLiVE

Sun Pharma recalls antidepressant in US

Withdraws more than 40,000 bottles of venlafaxine hydrochloride

dengue fever mosquito

Sanofi’s dengue vaccine could debut in 2015

End in sight after 20-year wait for first effective vaccine

EU flag

EMA transparency policy delayed over ‘wording’

Regulation on access to trial data postponed until October

Samsung incentivises African mHealth project with music

Will also offer discounted handsets and tablets to consumers and health workers

UK flag

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities

- PMLiVE

Pharma’s shrinking waterhole

A natural metaphor makes us think about our strategy

- PMLiVE

UDG buys Galliard and Nyxeon

Will add UK comms firms to Ashfield Healthcare Communications division

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links